Dabur India shares were up 2% after it reported a 7% year-on-year increase in consolidated net profit to Rs 560 crore for the December quarter, with revenue growing 6% to Rs 3,559 crore. The company’s FMCG business saw broad-based growth, with key brands gaining market share in India. International business also performed strongly, growing 11.1%.
Market bets on Aurobindo as Europe, US Sales show uptick
Aurobindo Pharma stock is performing well. Sales in Europe are improving. New products are launching in the US. The company is also developing weight loss